Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Article CommentaryCommentary

IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?

A. David Rodrigues
Drug Metabolism and Disposition November 2005, 33 (11) 1567-1575; DOI: https://doi.org/10.1124/dmd.105.006452
A. David Rodrigues
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 11 1567-1575
DOI 
https://doi.org/10.1124/dmd.105.006452
PubMed 
16118328

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 5, 2005
  • Accepted August 22, 2005
  • Published online October 26, 2005.

Article Versions

  • Earlier version (August 23, 2005 - 10:23).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. A. David Rodrigues
  1. Drug Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Princeton, New Jersey
  1. Address correspondence to:
    Dr. A. David Rodrigues, Bristol-Myers Squibb, Pharmaceutical Research Institute, Mailstop F14-04, P.O. Box 4000, Princeton, NJ 08543. E-mail: david.rodrigues{at}bms.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2005 to January 2021

AbstractFullPdf
Aug 2005370107
Sep 2005450174
Oct 200511331171
Nov 2005106151124
Dec 20054410355
Jan 2006403139
Feb 2006553035
Mar 2006482720
Apr 2006301819
May 2006292429
Jun 2006341822
Jul 200631310
Aug 2006181721
Sep 2006263223
Oct 2006372526
Nov 20062340067
Dec 20061840235
Jan 2007197353
Feb 2007238566
Mar 20071913391
Apr 2007298551
May 200789880
Jun 2007116465
Jul 200795642
Aug 2007138360
Sep 2007145042
Oct 2007186056
Nov 2007134446
Dec 2007105031
Jan 2008155344
Feb 2008135142
Mar 2008164239
Apr 2008147156
May 2008144838
Jun 2008124639
Jul 2008256846
Aug 2008316229
Sep 2008256949
Oct 2008155037
Nov 2008264633
Dec 2008184435
Jan 2009165237
Feb 2009145543
Mar 2009246640
Apr 2009133432
May 200984632
Jun 2009133926
Jul 2009203230
Aug 2009123829
Sep 20091349124
Oct 2009313426
Nov 2009321214
Dec 200922916
Jan 2010413638
Feb 2010294337
Mar 2010525049
Apr 2010333129
May 2010373022
Jun 2010404442
Jul 2010381723
Aug 2010283328
Sep 2010184130
Oct 2010413425
Nov 2010274127
Dec 2010313229
Jan 2011343226
Feb 2011232828
Mar 2011333841
Apr 2011283731
May 2011234642
Jun 2011211517
Jul 2011233334
Aug 2011173832
Sep 2011393530
Oct 2011325954
Nov 2011262935
Dec 2011213530
Jan 2012293329
Feb 2012324030
Mar 2012443427
Apr 2012194143
May 2012223932
Jun 2012244538
Jul 2012264136
Aug 2012232620
Sep 2012293734
Oct 2012294134
Nov 2012313430
Dec 2012303424
Jan 2013537142
Feb 2013485627
Mar 2013377128
Apr 2013254326
May 2013508427
Jun 2013275415
Jul 2013254121
Aug 2013312717
Sep 2013424525
Oct 2013364626
Nov 2013212618
Dec 2013213615
Jan 2014265428
Feb 2014164828
Mar 2014374628
Apr 2014356431
May 2014465229
Jun 2014514533
Jul 2014274616
Aug 2014184918
Sep 2014282818
Oct 2014263216
Nov 2014304225
Dec 201419177
Jan 2015222613
Feb 201515189
Mar 2015273919
Apr 2015251812
May 2015204621
Jun 2015174012
Jul 2015174729
Aug 2015253315
Sep 2015252825
Oct 201510296
Nov 201514188
Dec 201514229
Jan 2016313322
Feb 201612259
Mar 2016112627
Apr 2016102310
May 2016112415
Jun 2016113619
Jul 2016111917
Aug 201624217
Sep 2016122311
Oct 201613227
Nov 201622124
Dec 2016101610
Jan 20172178
Feb 20170184
Mar 201722010
Apr 201702210
May 201713014
Jun 20170255
Jul 201713710
Aug 20171174
Sep 20173206
Oct 201722814
Nov 201734316
Dec 201714115
Jan 20181384
Feb 201842510
Mar 201835124
Apr 2018250730
May 2018720424
Jun 2018022415
Jul 2018013722
Aug 201805329
Sep 201804012
Oct 2018014816
Nov 2018020235
Dec 20181444615
Jan 201912227
Feb 201917949
Mar 20195247
Apr 20194308
May 20192943
Jun 2019122412
Jul 201910313
Aug 201987811
Sep 201910326
Oct 20192945
Nov 20198164
Dec 20193566
Jan 20204642
Feb 20203445
Mar 20204221
Apr 20201522
May 20201801
Jun 20203021
Jul 2020934
Aug 2020624
Sep 20202032
Oct 20203946
Nov 20203265
Dec 202019127
Jan 20213067

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (11)
Drug Metabolism and Disposition
Vol. 33, Issue 11
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Article CommentaryCommentary

IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?

A. David Rodrigues
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1567-1575; DOI: https://doi.org/10.1124/dmd.105.006452

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Article CommentaryCommentary

IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?

A. David Rodrigues
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1567-1575; DOI: https://doi.org/10.1124/dmd.105.006452
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Kinetic Considerations
    • Nonselective COX Inhibitors
    • COX-2-Selective Inhibitors (COX-2/COX-1 IC50 Ratio ≤0.1)
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Reporting Data Analysis and Statistical Methods
  • Underestimation of d-Methylphenidate Bioavailability
  • Intracellular and Intraorgan Drug Concentrations
Show more COMMENTARIES

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics